As of May 29
| -0.63 / -1.19%|
The 16 analysts offering 12-month price forecasts for Metlife have a median target of 59.50, with a high estimate of 65.00 and a low estimate of 54.00. The median estimate represents a +13.85% increase from the last price of 52.26.
The current consensus among 20 polled investment analysts is to Buy stock in Metlife. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.